Somaxon Pharmaceuticals, Inc. (SOMX) Misses Q3 EPS by 30c
Tweet Send to a FriendGet Alerts SOMX Hot Sheet
Price: $3.00 --0%
Revenue Growth %: -43.2%
Financial Fact:
Total operating costs and expenses: 6.62M
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -43.2%
Financial Fact:
Total operating costs and expenses: 6.62M
Today's EPS Names:
ANF, DXLG, FL, More
Trade SOMX Now!
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) reported Q3 EPS of ($0.65), $0.30 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.3 million.
For earnings history and earnings-related data on Somaxon Pharmaceuticals, Inc. (SOMX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Somaxon Pharmaceuticals, Inc. (SOMX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Childrens Place (PLCE) Tops Q1 EPS by 22c; Boosts Outlook
- Gap, Inc. (GPS) Tops Q1 EPS by 2c; Reaffirms Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
